CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axisEmily Lerner, Peter E. Fecci|Nature Cancer|2023Cited by 131
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent <i>IDH</i> wild-type glioblastomaJohn de Groot, Eric C. Leuthardt, Adrian W. Laxton et al.|Neuro-Oncology Advances|2022Cited by 61
Autonomic modulation of the immune response and implications for CNS malignanciesLucas P. Wachsmuth, Peter E. Fecci, Ethan Srinivasan et al.|npj Precision Oncology|2025Cited by 6
Antigen presentation by tumor-associated macrophages drives tumor-infiltrating T cells from a progenitor exhaustion state to terminal exhaustionJessica Waibl Polania, Peter E. Fecci|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 3
Upregulation of TNFR2 Precedes TOX Expression by Exhausted T cells and Restricts Antitumor and Antiviral ImmunityAlexandra Miggelbrink, Peter E. Fecci|Clinical Cancer Research|2025Cited by 3